252 related articles for article (PubMed ID: 27902773)
1. Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype.
Kanemoto K; Fukuta K; Kawai N; Tozawa K; Ochiai M; Okamoto K; Ohnami S; Sakamoto H; Yoshida T; Kanai Y; Katoh M; Yasui T; Kohri K; Kakizoe T; Nakagama H
PLoS One; 2016; 11(11):e0167374. PubMed ID: 27902773
[TBL] [Abstract][Full Text] [Related]
2. Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells.
Shinoda Y; Kozaki K; Imoto I; Obara W; Tsuda H; Mizutani Y; Shuin T; Fujioka T; Miki T; Inazawa J
Cancer Sci; 2007 Jul; 98(7):1078-86. PubMed ID: 17459052
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P4502A6 (CYP2A6) expression in human hepatocellular carcinoma.
Raunio H; Juvonen R; Pasanen M; Pelkonen O; Pääkkö P; Soini Y
Hepatology; 1998 Feb; 27(2):427-32. PubMed ID: 9462641
[TBL] [Abstract][Full Text] [Related]
4. TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.
Zheng M; Simon R; Mirlacher M; Maurer R; Gasser T; Forster T; Diener PA; Mihatsch MJ; Sauter G; Schraml P
Am J Pathol; 2004 Jul; 165(1):63-9. PubMed ID: 15215162
[TBL] [Abstract][Full Text] [Related]
5. Function and regulation of the Cyp2a5/CYP2A6 genes in response to toxic insults in the liver.
Abu-Bakar A; Hakkola J; Juvonen R; Rahnasto-Rilla M; Raunio H; Lang MA
Curr Drug Metab; 2013 Jan; 14(1):137-50. PubMed ID: 22497566
[TBL] [Abstract][Full Text] [Related]
6. Bladder cancer stage and outcome by array-based comparative genomic hybridization.
Blaveri E; Brewer JL; Roydasgupta R; Fridlyand J; DeVries S; Koppie T; Pejavar S; Mehta K; Carroll P; Simko JP; Waldman FM
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7012-22. PubMed ID: 16203795
[TBL] [Abstract][Full Text] [Related]
7. Expression of cytochrome P450 2A5 in preneoplastic and neoplastic mouse liver lesions.
Wastl UM; Rossmanith W; Lang MA; Camus-Randon AM; Grasl-Kraupp B; Bursch W; Schulte-Hermann R
Mol Carcinog; 1998 Aug; 22(4):229-34. PubMed ID: 9726815
[TBL] [Abstract][Full Text] [Related]
8. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
[TBL] [Abstract][Full Text] [Related]
9. High-resolution array-based comparative genomic hybridization of bladder cancers identifies mouse double minute 4 (MDM4) as an amplification target exclusive of MDM2 and TP53.
Veerakumarasivam A; Scott HE; Chin SF; Warren A; Wallard MJ; Grimmer D; Ichimura K; Caldas C; Collins VP; Neal DE; Kelly JD
Clin Cancer Res; 2008 May; 14(9):2527-34. PubMed ID: 18451213
[TBL] [Abstract][Full Text] [Related]
10. Nicotine self-administration in mice is associated with rates of nicotine inactivation by CYP2A5.
Siu EC; Wildenauer DB; Tyndale RF
Psychopharmacology (Berl); 2006 Mar; 184(3-4):401-8. PubMed ID: 16485141
[TBL] [Abstract][Full Text] [Related]
11. Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA.
López V; González-Peramato P; Suela J; Serrano A; Algaba F; Cigudosa JC; Vidal A; Bellmunt J; Heredero O; Sánchez-Carbayo M
J Transl Med; 2013 Aug; 11():182. PubMed ID: 23914742
[TBL] [Abstract][Full Text] [Related]
12. Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma.
Nord H; Segersten U; Sandgren J; Wester K; Busch C; Menzel U; Komorowski J; Dumanski JP; Malmström PU; Díaz de Ståhl T
Int J Cancer; 2010 Mar; 126(6):1390-402. PubMed ID: 19821490
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of comparative molecular field analysis modelling of naphthalene inhibition of human CYP2A6 and mouse CYP2A5 enzymes.
Asikainen A; Tarhanen J; Poso A; Pasanen M; Alhava E; Juvonen RO
Toxicol In Vitro; 2003 Aug; 17(4):449-55. PubMed ID: 12849728
[TBL] [Abstract][Full Text] [Related]
14. Prenatal smoke exposure induces persistent
Lkhagvadorj K; Meyer KF; Verweij LP; Kooistra W; Reinders-Luinge M; Dijkhuizen HW; de Graaf IAM; Plösch T; Hylkema MN
Epigenetics; 2020 Dec; 15(12):1370-1385. PubMed ID: 32573327
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Cyp2a5 transcription in mouse primary hepatocytes: roles of hepatocyte nuclear factor 4 and nuclear factor I.
Ulvila J; Arpiainen S; Pelkonen O; Aida K; Sueyoshi T; Negishi M; Hakkola J
Biochem J; 2004 Aug; 381(Pt 3):887-94. PubMed ID: 15115437
[TBL] [Abstract][Full Text] [Related]
16. [Identification of gene expression patterns in superficial and invasive human bladder cancers].
Zhou L; Shi BT; Wang SX; Luo Y; Yang L; Zhang LL; Wang XY; He DL
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):798-801. PubMed ID: 17565857
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of ST6GAL1 in human bladder cancer.
Antony P; Rose M; Heidenreich A; Knüchel R; Gaisa NT; Dahl E
BMC Cancer; 2014 Dec; 14():901. PubMed ID: 25465919
[TBL] [Abstract][Full Text] [Related]
18. Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles.
Modlich O; Prisack HB; Pitschke G; Ramp U; Ackermann R; Bojar H; Vögeli TA; Grimm MO
Clin Cancer Res; 2004 May; 10(10):3410-21. PubMed ID: 15161696
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CYP2A6 in human colorectal tumors.
Matsuda Y; Saoo K; Yamakawa K; Yokohira M; Suzuki S; Kuno T; Kamataki T; Imaida K
Cancer Sci; 2007 Oct; 98(10):1582-5. PubMed ID: 17683511
[TBL] [Abstract][Full Text] [Related]
20. High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer.
Simon R; Richter J; Wagner U; Fijan A; Bruderer J; Schmid U; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Anabitarte M; Hering F; Hardmeier T; Schönenberger A; Flury R; Jäger P; Fehr JL; Schraml P; Moch H; Mihatsch MJ; Gasser T; Sauter G
Cancer Res; 2001 Jun; 61(11):4514-9. PubMed ID: 11389083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
